Fig. 1 · Structure
Documents & Downloads
Prifetrastat
KAT6A/B Inhibitor
Prifetrastat is a selective, orally active KAT6A and KAT6B inhibitor. This compound demonstrates potent inhibitory activity against KAT6A and KAT6B, making it a valuable tool for investigating the role of these targets in various biological processes. Prifetrastat is particularly relevant for research applications focused on ER+/HER2− breast cancer, providing insights into potential therapeutic strategies for this subtype.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 2569008-99-5 |
| Applications | KAT6A/B Inhibitor |
| Formula | C19H18N4O5S |
| Molecular Weight | 414.44 |
| Synonyms | PF-07248144 |
| SMILES | O=S(NC1=NOC2=CC(CN3N=CC=C3)=CC(OC)=C21)(C4=C(OC)C=CC=C4)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.